Butalbital, Aspirin, And Caffeine 00781-2270
Product NDC
00781-2270- Manufacturer
- Sandoz Inc
- Dosage Form
- Capsule
- Route
- Oral
- Product Type
- Human Prescription Drug
- DEA Schedule
- Schedule CIII
- Marketing Start
- September 3, 2024
- Listing Expires
- December 31, 2026
- Application
- ANDA086996
Active Ingredients
| Ingredient | Strength |
|---|---|
| Aspirin | 325 mg/1 |
| Butalbital | 50 mg/1 |
| Caffeine | 40 mg/1 |
Drug Class
Nonsteroidal Anti-inflammatory Drug [EPC]Platelet Aggregation Inhibitor [EPC]Barbiturate [EPC]
Packaging Options(1)
100 CAPSULE in 1 BOTTLE (0781-2270-01)